Skip to main content
QTIH
OTC Industrial Applications And Services

QT Imaging Secures Exclusive UAE Distribution Agreement, Projecting Over $24M in Revenue

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$5.72
Mkt Cap
$68.081M
52W Low
$0.621
52W High
$9.209
52W Position info
821% above low
Off High info
38% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

QTIH has more than doubled off its 52-week low of $0.621 on light trading volume (0.2× avg).

Summary

QT Imaging Holdings, Inc. has signed an exclusive distribution agreement with Al Naghi Medical Co. for its breast imaging scanners and cloud platform in the UAE, projecting over $24 million in revenue from minimum orders over three years.


Key Events · M&A and Partnerships · QTIH

  • Exclusive Distribution Agreement

    QT Imaging Holdings entered into an exclusive distribution agreement with Al Naghi Medical Co. for its QT Breast Acoustic CT Scanners and QTI Cloud Platform in the United Arab Emirates.

  • Significant Revenue Runway

    The agreement is projected to generate over $24 million in revenue from minimum orders over the initial three-year term (2026-2028).

  • Market Penetration

    This partnership provides exclusive access to the UAE, a key Middle Eastern healthcare market with a high incidence of breast cancer, particularly among younger women.

  • Minimum Order Commitments

    The agreement includes committed minimum order quantities, starting with 7 scanners in 2026 (Q2 onwards), 16 in 2027, and 20 in 2028, ensuring a predictable revenue stream.


Analysis · QTIH · Industrial Applications And Services

This exclusive distribution agreement with Al Naghi Medical Co. for the United Arab Emirates is a highly significant development for QT Imaging Holdings. The projected revenue of over $24 million from minimum orders over the next three years represents a substantial new revenue stream relative to the company's current market capitalization. This partnership provides a critical entry into a growing Middle Eastern healthcare market, particularly relevant given the higher prevalence and younger diagnosis age of breast cancer in the UAE, aligning well with QT Imaging's non-invasive technology. The agreement's minimum purchase requirements offer a degree of revenue predictability, and the commencement of shipments in Q2 2026 indicates a near-term positive impact on financial performance.

At the time of this filing, QTIH was trading at $5.72 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $68.1M. The 52-week trading range was $0.62 to $9.21. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QTIH - Latest Insights

QTIH
Jan 27, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.50
Real-time Price: $6.60 info
Change: +$0.100 (+2%) info
Market Cap: $77.364M info
QTIH
Jan 23, 2026, 9:04 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.85
Real-time Price: $6.60 info
Change: +$0.750 (+13%) info
Market Cap: $77.364M info